Ziegler Capital Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Ziegler Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	$528K	Hold	13,969	–	–	0.05%	286
2013 Q2	$548K	Buy	+13,969	New	+$544K	0.06%	294

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Ziegler Capital Management's TEVA Position: Q3 2013 in Review

Ziegler Capital Management held its Teva Pharmaceutical Industries Limited (TEVA) position steady in Q3 2013 at 13,969 shares worth $528K. The position accounts for 0.05% of the portfolio, ranked #286.

Ziegler Capital Management first reported a position in TEVA in Q2 2013 and has held it in 2 quarters since. The position peaked at $548K in Q2 2013. 705 funds tracked by Wall St. Rank hold TEVA as of Q3 2013.

Ziegler Capital Management held 13,969 shares of Teva Pharmaceutical Industries Limited worth $528K as of Q3 2013.
Ziegler Capital Management left its Teva Pharmaceutical Industries Limited share count unchanged in Q3 2013.
Teva Pharmaceutical Industries Limited made up 0.05% of Ziegler Capital Management's portfolio in Q3 2013, its #286 holding.
Ziegler Capital Management first reported a position in Teva Pharmaceutical Industries Limited in Q2 2013 and has held it in 2 quarters since.
Ziegler Capital Management's Teva Pharmaceutical Industries Limited position peaked at $548K in Q2 2013.
705 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2013.

Based on Ziegler Capital Management's 13F filing for Q3 2013, filed 6 Nov 2013.